Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
5.63M
-
Shares change
-
+2.33M
-
Total reported value, excl. options
-
$33.1M
-
Value change
-
+$14M
-
Number of buys
-
32
-
Number of sells
-
-16
-
Price
-
$5.88
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q4 2017
61 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q4 2017.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.63M shares
of 79.8M outstanding shares and own 7.05% of the company stock.
Largest 10 shareholders include ICONIQ Capital, LLC (1.71M shares), Vanguard Group Inc (1.01M shares), Tieton Capital Management, LLC (568K shares), MILLENNIUM MANAGEMENT LLC (543K shares), Granite Investment Partners, LLC (250K shares), Precept Management LLC (200K shares), GEODE CAPITAL MANAGEMENT, LLC (175K shares), North Star Investment Management Corp. (153K shares), BlackRock Inc. (111K shares), and BARCLAYS PLC (103K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.